Busca un médico

Keith G. Rasmussen, Jr., M.D.

  1. Psychiatrist

Publicaciones

  1. Allen ND, Allison CL, Golebiowski R, Janowski JPB, LeMahieu AM, Geske JR, Rasmussen KG. Factors Associated With Postictal Agitation After Electroconvulsive Therapy. J ECT. 2022 Mar 1; 38 (1):60-61
    View PubMed
  2. Singh B, Bobo WV, Rasmussen KG, Stoppel CJ, Rico JA Jr, Schak KM, Biernacka JM, Frye MA, Vande Voort JL. The Association Between Body Mass Index and Remission Rates in Patients With Treatment-Resistant Depression Who Received Intravenous Ketamine. J Clin Psychiatry 2019 Nov 12; 80 (6)
    View PubMed
  3. Lee JH, Kung S, Rasmussen KG, Palmer BA. Effectiveness of Electroconvulsive Therapy in Patients With Major Depressive Disorder and Comorbid Borderline Personality Disorder. J ECT. 2019 Mar; 35 (1):44-47
    View PubMed
  4. Shafi RMA, Kung S, Johnson EK, Lapid MI, Rasmussen KG. Decreasing Treatment Duration of Electroconvulsive Therapy (ECT) Using Daily Right Unilateral Ultrabrief Instead of Bitemporal ECT. J Psychiatr Pract. 2018 Nov; 24 (6):410-415
    View PubMed
  5. Shafi R, Kung S, Johnson E, Rasmussen K, Lapid M. Clinical Outcomes of Daily Right Unilateral Ultrabrief ECT Compared With Bitemporal ECT: A Retrospective Review of 214 Patients Under Review: Journal of Psychiatry Practice. 2018.
  6. Rasmussen KG. The PRIDE Study and the Conduct of Electroconvulsive Therapy: Questions Answered and Unanswered. J ECT. 2017 Dec; 33 (4):225-228
    View PubMed
  7. Lamoureux IC, Schutt PE, Rasmussen KG. Petitioning for Involuntary Commitment for Chemical Dependency by Medical Services. J Am Acad Psychiatry Law. 2017 Sep; 45 (3):332-338
    View PubMed
  8. Rasmussen KG. Ketamine for the Treatment of Depression. JAMA Psychiatry 2017 Sep 1; 74 (9):970-971
    View PubMed
  9. Rasmussen KG. Searching for Optimal Treatment Schedules for Longitudinal ECT. Am J Psychiatry 2017 Apr 1; 174 (4):397
    View PubMed
  10. Vande Voort JL, Morgan RJ, Kung S, Rasmussen KG, Rico J, Palmer BA, Schak KM, Tye SJ, Ritter MJ, Frye MA, Bobo WV. Continuation phase intravenous ketamine in adults with treatment-resistant depression. J Affect Disord. 2016 Dec; 206:300-304. Epub 2016 Sep 12.
    View PubMed
  11. Allen ND, Leung JG, Betcher HK, Borreggine KL, Hosker DK, Minton BA, Sukiennik EM, Wilson JJ, Philbrick KL, Rasmussen KG. Mirtazapine for Symptomatic Relief on a Psychiatric Consultation Service: A Case Series. Psychosomatics. 2016 Jul-Aug; 57 (4):409-13 Epub 2016 Mar 02
    View PubMed
  12. Schak KM, Vande Voort JL, Johnson EK, Kung S, Leung JG, Rasmussen KG, Palmer BA, Frye MA. Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment. Am J Psychiatry. 2016 Mar 1; 173 (3):215-8
    View PubMed
  13. Sutor B, Rasmussen KG. Clinical Challenges in Maintenance Electroconvulsive Therapy for Older Patients With Medical Comorbidity. J ECT. 2016 Mar; 32: (1)67-9.
    View PubMed
  14. Rasmussen KG. What Type of Cognitive Testing Should Be Part of Routine Electroconvulsive Therapy Practice? J ECT. 2016 Mar; 32: (1)7-12.
    View PubMed
  15. Rasmussen KG, Johnson EK, Kung S, Farrow SL, Brown SK, Govrik MN, Citronowicz RI. An Open-Label, Pilot Study of Daily Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy. J ECT. 2016 Mar; 32: (1)33-7.
    View PubMed
  16. Rasmussen KG. Has psychiatry tamed the "ketamine tiger?" Considerations on its use for depression and anxiety. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4; 64:218-24.
    View PubMed
  17. Barreto JN, Leung JG, Philbrick KL, Rasmussen KG, Thompson CA. Clozapine therapy throughout myelosuppressive chemotherapy: regulations without standardization. Psychooncology. 2015 Nov; 24: (11)1581-5.
    View PubMed
  18. Dare FY, Rasmussen KG. Court-Approved Electroconvulsive Therapy in Patients Unable to Provide Their Own Consent: A Case Series. J ECT. 2015 Sep; 31: (3)147-9.
    View PubMed
  19. Leung JG, Dare FY, Flowers LM, Murphy LL, Sukiennik EM, Philbrick KL, Rasmussen KG. Thiothixene in the Management of Delirium: A Case Series. Psychosomatics. 2015 Sep-Oct; 56: (5)542-6.
    View PubMed
  20. Rasmussen KG. Lithium for post-electroconvulsive therapy depressive relapse prevention: a consideration of the evidence. J ECT. 2015 Jun; 31: (2)87-90.
    View PubMed
  21. Rasmussen KG. Do patients with personality disorders respond differentially to electroconvulsive therapy? A review of the literature and consideration of conceptual issues. J ECT. 2015 Mar; 31: (1)6-12.
    View PubMed
  22. Kellner CH, Rasmussen KG. Contemporary ect for depression part 1: practice update Psychiatric Times. 2015; 32: (7)53-5.
  23. Kellner CH, Rasmussen KG. Contemporary ect, part 2: mechanism of action and future research directions Psychiatric Times. 2015; 32: (8)50-7.
  24. Rasmussen KG, Ritter MJ. Some considerations of the tolerability of ketamine for ECT anesthesia: a case series and review of the literature. J ECT. 2014 Dec; 30(4):283-6.
    View PubMed
  25. Rasmussen KG. Propofol for ECT anesthesia a review of the literature. J ECT. 2014 Sep; 30 (3):210-5
    View PubMed
  26. Rasmussen KG, Ritter MJ. Anesthetic-induced pain on injection in electroconvulsive therapy: review of the literature and suggestions for prevention. J ECT. 2014 Sep; 30(3):203-9.
    View PubMed
  27. Rasmussen KG. Psychiatric side effects of ketamine in hospitalized medical patients administered subanesthetic doses for pain control. Acta Neuropsychiatr. 2014 Aug; 26(4):230-3.
    View PubMed
  28. Rasmussen KG, Kung S, Lapid MI, Oesterle TS, Geske JR, Nuttall GA, Oliver WC, Abenstein JP. A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy. Psychiatry Res. 2014 Feb 28; 215 (2):362-5 Epub 2013 Dec 21
    View PubMed
  29. Rasmussen KG, Lineberry TW, Galardy CW, Kung S, Lapid MI, Palmer BA, Ritter MJ, Schak KM, Sola CL, Hanson AJ, Frye MA. Serial infusions of low-dose ketamine for major depression. J Psychopharmacol. 2013 May; 27 (5):444-50 Epub 2013 Feb 20
    View PubMed
  30. Vande Voort JL, Swintak CC, Wall CA, Rasmussen KG Jr. Methohexital-induced seizures during electroconvulsive therapy. J ECT. 2013 Mar; 29 (1):e4-5
    View PubMed
  31. Rasmussen KG. A randomized controlled trial of ketorolac for prevention of headache related to electroconvulsive therapy. Pain Studies and Treatment. 2013; 1(2):5-8.
  32. Rasmussen KG. Electroconvulsive therapy and melancholia: review of the literature and suggestions for further study. J ECT. 2011 Dec; 27(4):315-22.
    View PubMed
  33. Pullen SJ, Rasmussen KG, Angstman ER, Rivera F, Mueller PS. The safety of electroconvulsive therapy in patients with prolonged QTc intervals on the electrocardiogram. J ECT. 2011 Sep; 27(3):192-200.
    View PubMed
  34. Rasmussen KG, Richardson JW. Electroconvulsive therapy in palliative care. Am J Hosp Palliat Care. 2011 Aug; 28(5):375-7. Epub 2010 Nov 17.
    View PubMed
  35. Martinez MW, Rasmussen KG, Mueller PS, Jaffe AS. Troponin elevations after electroconvulsive therapy: the need for caution. Am J Med. 2011 Mar; 124(3):229-34.
    View PubMed
  36. Rasmussen KG. Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression. J ECT. 2011 Mar; 27 (1):51-4
    View PubMed
  37. Bailine S, Fink M, Knapp R, Petrides G, Husain MM, Rasmussen K, Sampson S, Mueller M, McClintock SM, Tobias KG, Kellner CH. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand. 2010 Jun; 121(6):431-6. Epub 2009 Nov 08.
    View PubMed
  38. Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M, McClintock SM, Tobias KG, Martino C, Mueller M, Bailine SH, Fink M, Petrides G. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010 Mar; 196(3):226-34.
    View PubMed
  39. Rasmussen KG, Stevens SR, Kung S, Mohan A. Melancholic symptoms as assessed by the Hamilton Depression Rating Scale and outcomes with and without electroconvulsive therapy on an in-patient mood disorders unit. Acta Neuropsychiatr. 2010 Feb; 22(1):21-5.
    View PubMed
  40. Smith GE, Rasmussen KG, Cullum CM, Felmlee-Devine MD, Petrides G, Rummans TA, Husain MM, Mueller M, Bernstein HJ, Knapp RG, O'Connor MK, Fink M, Sampson S, Bailine SH, Kellner CH, CORE Investigators. A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study. J Clin Psychiatry. 2010 Feb; 71(2):185-93.
    View PubMed
  41. Mueller PS, Albin SM, Barnes RD, Rasmussen KG Jr. Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: report of 8 patients. J ECT. 2009 Sep; 25(3):165-9.
    View PubMed
  42. Rasmussen KG. Sham electroconvulsive therapy studies in depressive illness: a review of the literature and consideration of the placebo phenomenon in electroconvulsive therapy practice. J ECT. 2009 Mar; 25(1):54-9.
    View PubMed
  43. Rasmussen KG, Imig MW, Varghese R. Remifentanil/Thiopental combination and seizure length in electroconvulsive therapy. J ECT. 2009 Mar; 25 (1):31-3
    View PubMed
  44. Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). J Clin Psychiatry. 2009 Feb; 70 (2):232-7 Epub 2009 Jan 13
    View PubMed
  45. Rasmussen KG, Black JL. Serotonin transporter gene status and electroconvulsive therapy outcomes: a retrospective analysis of 83 patients. J Clin Psychiatry. 2009 Jan; 70 (1):92-4 Epub 2008 Dec 30
    View PubMed
  46. Sutor B, Rasmussen K. Long-term maintenance electroconvulsive therapy in the treatment of schizophrenia and schizoaffective disorder-A case series. Clinical Schizophrenia and Related Psychoses. 2009; 2(4):326-30.
  47. Sutor B, Mueller PS, Rasmussen KG. Bradycardia and hypotension in a patient with severe aortic stenosis receiving electroconvulsive therapy dose titration for treatment of depression. J ECT. 2008 Dec; 24: (4)281-2.
    View PubMed
  48. Rasmussen KG. Electroconvulsive therapy versus transcranial magnetic stimulation for major depression: A review with recommendations for future research. Acta Neuropsychiatrica. 2008 Dec; 20(6):291-4.
  49. Sutor B, Rasmussen KG. Electroconvulsive therapy for agitation in Alzheimer disease: a case series. J ECT. 2008 Sep; 24(3):239-41.
    View PubMed
  50. Hooten WM, Rasmussen KG Jr. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. J ECT. 2008 Sep; 24 (3):208-23
    View PubMed
  51. Rasmussen KG, Albin SM, Mueller PS, Abel MD. Electroconvulsive therapy in patients taking steroid medication: should supplemental doses be given on the days of treatment? J ECT. 2008 Jun; 24(2):128-30.
    View PubMed
  52. Williams MD, Rummans T, Sampson S, Knapp R, Mueller M, Husain MM, Fink M, Rasmussen K, O'Connor K, O'Connor K, Smith G, Petrides G, Kellner CH. Outcome of electroconvulsive therapy by race in the Consortium for Research on Electroconvulsive Therapy multisite study. J ECT. 2008 Jun; 24 (2):117-21
    View PubMed
  53. Fink M, Petrides G, Kellner C, Mueller M, Knapp R, Husain MM, Rasmussen K, Rummans T, O'Connor K, CORE Group. Change in seizure threshold during electroconvulsive therapy. J ECT. 2008 Jun; 24(2):114-6.
    View PubMed
  54. Rasmussen KG, Leise AD, Stevens SR. Orthostatic hemodynamic changes after electroconvulsive therapy treatments. J ECT. 2008 Jun; 24(2):134-6.
    View PubMed
  55. Dodd ML, Dolenc TJ, Karpyak VM, Rasmussen KG. QTc dispersion in patients referred for electroconvulsive therapy. J ECT. 2008 Jun; 24(2):131-3.
    View PubMed
  56. Schak KM, Mueller PS, Barnes RD, Rasmussen KG. The safety of ECT in patients with chronic obstructive pulmonary disease. Psychosomatics. 2008 May-Jun; 49(3):208-11.
    View PubMed
  57. Rasmussen KG, Petersen KN, Sticka JL, Wieme LJ, Zosel JH, Marienau ME, Ryan DA, Schroeder DR, Stevens SR, Hooten WM, Spackman TN. Correlates of myalgia in electroconvulsive therapy. J ECT. 2008 Mar; 24(1):84-7.
    View PubMed
  58. Husain MM, McClintock SM, Rush AJ, Knapp RG, Fink M, Rummans TA, Rasmussen K, Claassen C, Petrides G, Biggs MM, Mueller M, Sampson S, Bailine SH, Lisanby SH, Kellner CH. The efficacy of acute electroconvulsive therapy in atypical depression. J Clin Psychiatry. 2008 Mar; 69(3):406-11.
    View PubMed
  59. Rasmussen KG, Hart DA, Lineberry TW. ECT in patients with psychopathology related to acute neurologic illness. Psychosomatics. 2008 Jan-Feb; 49(1):67-72.
    View PubMed
  60. Rasmussen KG, Knapp RG, Biggs MM, Smith GE, Rummans TA, Petrides G, Husain MM, O'Connor MK, Fink M, O'Connor MK, Kellner CH. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial. J ECT. 2007 Dec; 23 (4):244-50
    View PubMed
  61. Rasmussen KG, Laurila DR, Brady BM, Lewis CL, Niemeyer KD, Sun NM, Marienau ME, Hooten WM, Schroeder DR, Spackman TM. Anesthesia outcomes in a randomized double-blind trial of sevoflurane and thiopental for induction of general anesthesia in electroconvulsive therapy. J ECT. 2007 Dec; 23 (4):236-8
    View PubMed
  62. Mueller PS, Barnes RD, Varghese R, Nishimura RA, Rasmussen KG. The safety of electroconvulsive therapy in patients with severe aortic stenosis. Mayo Clin Proc. 2007 Nov; 82(11):1360-3.
    View PubMed
  63. Rasmussen KG, Mueller M, Knapp RG, Husain MM, Rummans TA, Sampson SM, O'Connor MK, Petrides G, Fink M, Kellner CH. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy. J Clin Psychiatry. 2007 Nov; 68 (11):1701-6
    View PubMed
  64. Rasmussen KG, Varghese R, Stevens SR, Ryan DA. Electrode placement and ictal EEG indices in electroconvulsive therapy. J Neuropsychiatry Clin Neurosci. 2007 Fall; 19(4):453-7.
    View PubMed
  65. Rasmussen KG, Keegan BM. Electroconvulsive therapy in patients with multiple sclerosis. J ECT. 2007 Sep; 23(3):179-80.
    View PubMed
  66. Rasmussen KG, Mohan A, Stevens SR. Serum sodium does not correlate with seizure length or seizure threshold in electroconvulsive therapy. J ECT. 2007 Sep; 23(3):175-6.
    View PubMed
  67. Fink M, Rush AJ, Knapp R, Rasmussen K, Mueller M, Rummans TA, O'Connor K, Husain M, Biggs M, Bailine S, Kellner CH, Consortium for Research in ECT (CORE) Study Group. DSM melancholic features are unreliable predictors of ECT response: a CORE publication. J ECT. 2007 Sep; 23(3):139-46.
    View PubMed
  68. Rasmussen KG, Hooten WM, Dodd ML, Ryan DA. QTc dispersion on the baseline ECG predicts arrhythmias during electroconvulsive therapy. Acta Cardiol. 2007 Aug; 62: (4)345-7.
    View PubMed
  69. Rasmussen KG, Lineberry TW. Patients who inappropriately demand electroconvulsive therapy. J ECT. 2007 Jun; 23(2):109-13.
    View PubMed
  70. Rasmussen KG, Lunde ME. Patients who develop epilepsy during extended treatment with electroconvulsive therapy. Seizure. 2007 Apr; 16(3):266-70. Epub 2006 Dec 20.
    View PubMed
  71. Albin SM, Stevens SR, Rasmussen KG. Blood pressure before and after electroconvulsive therapy in hypertensive and nonhypertensive patients. J ECT. 2007 Mar; 23(1):9-10.
    View PubMed
  72. Rasimas JJ, Stevens SR, Rasmussen KG. Seizure length in electroconvulsive therapy as a function of age, sex, and treatment number. J ECT. 2007 Mar; 23(1):14-6.
    View PubMed
  73. Rasmussen KG. Attempts to validate melancholic depression: some observations on modern research methodology. Bull Menninger Clin. 2007 Spring; 71(2):150-63.
    View PubMed
  74. Perry CL, Lindell EP, Rasmussen KG. ECT in patients with arachnoid cysts. J ECT. 2007 Mar; 23 (1):36-7
    View PubMed
  75. Rasmussen KG, Perry CL, Sutor B, Moore KM. ECT in patients with intracranial masses. J Neuropsychiatry Clin Neurosci. 2007 Spring; 19(2):191-3.
    View PubMed
  76. Mueller PS, Schak KM, Barnes RD, Rasmussen KG. Safety of electroconvulsive therapy in patients with asthma. Neth J Med. 2006 Dec; 64(11):417-21.
    View PubMed
  77. Rasmussen KG, Laurila DR, Brady BM, Lewis CL, Niemeyer KD, Sun NM, Marienau ME, Hooten WM, Schroeder DR, Spackman TM. Seizure length with sevoflurane and thiopental for induction of general anesthesia in electroconvulsive therapy: a randomized double-blind trial. J ECT. 2006 Dec; 22 (4):240-2
    View PubMed
  78. Rasmussen KG, Flemming KD. Electroconvulsive therapy in patients with cavernous hemangiomas. J ECT. 2006 Dec; 22(4):272-3.
    View PubMed
  79. Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, Mueller M, Bernstein HJ, O'Connor K, Smith G, Biggs M, Bailine SH, Malur C, Yim E, McClintock S, Sampson S, Fink M. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006 Dec; 63(12):1337-44.
    View PubMed
  80. Lunde ME, Lee EK, Rasmussen KG. Electroconvulsive therapy in patients with epilepsy. Epilepsy Behav. 2006 Sep; 9(2):355-9. Epub 2006 Jul 28.
    View PubMed
  81. Rasmussen KG, Mueller M, Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, O'connor MK, O'connor MK, Black JL, Sampson S, Fink M, CORE group. Patterns of psychotropic medication use among patients with severe depression referred for electroconvulsive therapy: data from the Consortium for Research on Electroconvulsive Therapy. J ECT. 2006 Jun; 22 (2):116-23
    View PubMed
  82. Rasmussen KG, Ryan DA, Mueller PS. Blood glucose before and after ECT treatments in Type 2 diabetic patients. J ECT. 2006 Jun; 22 (2):124-6
    View PubMed
  83. Teman PT, Perry CL, Ryan DA, Rasmussen KG. Nonconvulsive seizures in electroconvulsive therapy: further evidence of differential neurophysiological aspects of bitemporal versus bifrontal electrode placement. J ECT. 2006 Mar; 22 (1):46-8
    View PubMed
  84. Teman PT, Perry CL, Ryan DA, Rasmussen KG. Non-convulsive seizures in ECT: Further evidence of differential neurophysiological aspects of bitemporal versus bifrontal electrode placement. Journal of ECT.. 2006; 22: (1)46-8.
  85. Rasmussen KG. Electroconvulsive therapy and medical illness. Psychiatric Times. 2006; 23(5):19-22.
  86. Rasmussen KG, Spackman TN, Hooten WM. The clinical utility of inhalational anesthesia with sevoflurane in electroconvulsive therapy. J ECT. 2005 Dec; 21 (4):239-42
    View PubMed
  87. Rasmussen KG, Ryan DA. The effect of electroconvulsive therapy treatments on blood sugar in nondiabetic patients. J ECT. 2005 Dec; 21 (4):232-4
    View PubMed
  88. Dolenc TJ, Rasmussen KG. The safety of electroconvulsive therapy and lithium in combination: a case series and review of the literature. J ECT. 2005 Sep; 21 (3):165-70
    View PubMed
  89. Kellner CH, Fink M, Knapp R, Petrides G, Husain M, Rummans T, Mueller M, Bernstein H, Rasmussen K, O'Connor K, Smith G, Rush AJ, Biggs M, McClintock S, Bailine S, Malur C. Relief of expressed suicidal intent by ECT: A consortium for research in ECT study. Am J Psychiatry. 2005 May; 162(5):977-82.
    View PubMed
  90. Rasmussen KG, Snyder KA, Knapp RG, Mueller M, Yim E, Husain MM, Rummans TA, Sampson SM, O'Connor MK, Bernstein HJ, Kellner CH, CORE Group. Relationship between somatization and remission with ECT. Psychiatry Res. 2004 Dec 30; 129(3):293-5.
    View PubMed
  91. Dolenc TJ, Habl SS, Barnes RD, Rasmussen KG. Electroconvulsive therapy in patients taking monoamine oxidase inhibitors. J ECT. 2004 Dec; 20 (4):258-61
    View PubMed
  92. Nuttall GA, Bowersox MR, Douglass SB, McDonald J, Rasmussen LJ, Decker PA, Oliver WC Jr, Rasmussen KG. Morbidity and mortality in the use of electroconvulsive therapy. J ECT. 2004 Dec; 20 (4):237-41
    View PubMed
  93. Dolenc TJ, Barnes RD, Hayes DL, Rasmussen KG. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004 Sep; 27(9):1257-63.
    View PubMed
  94. Karpyak VM, Rasmussen KG, Hammill SC, Mrazek DA. Changes in heart rate variability in response to treatment with electroconvulsive therapy. J ECT. 2004 Jun; 20 (2):81-8
    View PubMed
  95. Husain MM, Rush AJ, Fink M, Knapp R, Petrides G, Rummans T, Biggs MM, O'Connor K, Rasmussen K, Litle M, Zhao WL, Bernstein HJ, Smith G, Mueller M, McClintock SM, Bailine SH, Kellner CH. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): A Consortium for Research in ECT (CORE) report. J Clin Psychiatry. 2004 Apr; 65(4):485-91.
    View PubMed
  96. Good MS, Dolenc TJ, Rasmussen KG. Electroconvulsive therapy in a patient with glaucoma. J ECT. 2004 Mar; 20 (1):48-9
    View PubMed
  97. Rasmussen KG, Karpyak VM, Hammill SC. Lack of effect of ECT on Holter monitor recordings before and after treatment. J ECT. 2004 Mar; 20 (1):45-7
    View PubMed
  98. Rasmussen KG. Clinical applications of recent research on electroconvulsive therapy. Bull Menninger Clin. 2003 Winter; 67 (1):18-31
    View PubMed
  99. Lapid MI, Rummans TA, Poole KL, Pankratz VS, Maurer MS, Rasmussen KG, Philbrick KL, Appelbaum PS. Decisional capacity of severely depressed patients requiring electroconvulsive therapy. J ECT. 2003 Jun; 19(2):67-72.
    View PubMed
  100. Rasmussen KG Jr, Russell JC, Kung S, Rummans TA, Rae-Stuart E, O'Connor MK, O'Connor MK. Electroconvulsive therapy for patients with major depression and probable Lewy body dementia. J ECT. 2003 Jun; 19 (2):103-9
    View PubMed
  101. Russell JC, Rasmussen KG, O'Connor MK, O'Connor MK, Copeman CA, Ryan DA, Rummans TA. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT. 2003 Mar; 19 (1):4-9
    View PubMed
  102. Barker SB, Rasmussen KG, Best AM. Effect of aquariums on electroconvulsive therapy patients. Anthrozoos. 2003; 16(3):229-40.
  103. Rasmussen KG. The role of electroconvulsive therapy in chronic pain. Reviews in Analgesia. 7(1). 03. 61-68.
  104. Rasmussen KG, Sampson SM, Rummans TA. Electroconvulsive therapy and newer modalities for the treatment of medication-refractory mental illness. Mayo Clin Proc. 2002 Jun; 77(6):552-6.
    View PubMed
  105. Rasmussen KG, Rummans TA, Richardson JW. Electroconvulsive therapy in the medically ill. Psychiatr Clin North Am. 2002 Mar; 25 (1):177-93
    View PubMed
  106. Netzel PJ, Mueller PS, Rummans TA, Rasmussen KG, Pankratz VS, Lohse CM. Safety, efficacy, and effects on glycemic control of electroconvulsive therapy in insulin-requiring type 2 diabetic patients. J ECT. 2002 Mar; 18 (1):16-21
    View PubMed
  107. Rasmussen K. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (second edition). J ECT. 2002 Mar; 18 (1):58-9
    View PubMed
  108. Rasmussen KG, Rummans TA. Electroconvulsive therapy in the management of chronic pain. Curr Pain Headache Rep. 2002 Feb; 6 (1):17-22
    View PubMed
  109. Rasmussen KG. When is ECT indicated in psychiatric disorders? Current Psychiatry. 2002; 1(2):21-26.
  110. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, Rummans TA, O'Connor KM, Rasmussen KG Jr, Bernstein HJ, Biggs M, Bailine SH, Kellner CH. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001 Dec; 17(4):244-53.
    View PubMed
  111. Rasmussen KG, Rummans TA. Electroconvulsive therapy for phantom limb pain. Pain. 2000 Mar; 85 (1-2):297-9
    View PubMed
  112. Rasmussen KG, Pandurangi AK. Naloxone fails to prolong seizure length in ECT. J ECT. 1999 Dec; 15(4):258-61.
    View PubMed
  113. Rasmussen KG, Jarvis MR, Zorumski CF, Ruwitch J, Best AM. Low-dose atropine in electroconvulsive therapy. J ECT. 1999 Sep; 15(3):213-21.
    View PubMed
  114. Rasmussen KG. Electroconvulsive therapy in patients with aortic stenosis. Convuls Ther. 1997 Sep; 13(3):196-9.
    View PubMed
  115. Rasmussen KG, Jarvis MR, Zorumski CF. Ketamine anesthesia in electroconvulsive therapy. Convuls Ther. 1996 Dec; 12(4):217-23.
    View PubMed
  116. Swartz CM, Abrams R, Rasmussen K, Zorumski CF. Visually determined high-frequency seizure activity. Convuls Ther. 1994 Sep; 10(3):224-7.
    View PubMed
  117. Rasmussen KG, Zorumski CF, Jarvis MR. Possible impact of stimulus duration on seizure threshold in ECT. Convuls Ther. 1994 Jun; 10(2):177-80.
    View PubMed
  118. Swartz CM, Abrams R, Rasmussen K, Pavel J, Zorumski CF, Srinivasaraghavan J. Computer automated versus visually determined electroencephalographic and electromyographic seizure duration. Convuls Ther. 1994 Jun; 10(2):165-70.
    View PubMed
  119. Rasmussen KG, Zorumski CF. Electroconvulsive therapy in patients taking theophylline. J Clin Psychiatry. 1993 Nov; 54(11):427-31.
    View PubMed
  120. Jarvis MR, Zorumski CF, Goewert AJ, Rasmussen KG. Maintenance electroconvulsive therapy and seizure duration. Convuls Ther. 1993; 9:8-13.
    View PubMed
  121. Rasmussen KG, Zorumski CF, Jarvis MR. Electroconvulsive Therapy in Patients with Cerebral Palsy. Convuls Ther. 1993; 9(3):205-8.
    View PubMed
  122. Rasmussen KG. Nonverbal behavior, verbal behavior, resume credentials, and selection interview outcomes. J Appl Psychol. 1984; 49:551-556.
PST-20220681